Suchergebnisse - "Altuntas, Fevzi"

PubPharm (226)

1

Evaluation of oral manifestations and head and neck lymphadenopathy in newly diagnosed acute leukemia patients

enthalten in: Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry | 2023

von Pamukcu, U. | Dal, M. | Yaman, S. | +6

2

Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV) : a multicentre, randomised, placebo-controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Broome, C. | McDonald, V. | Miyakawa, Y. | +83

3

Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients : a multicenter experience in Turkey

enthalten in: Journal of chemotherapy (Florence, Italy) | 2023

von Bakırtaş, M. | Dal, M. | Yiğenoğlu, T. | +17

4

An effective treatment in Erdheim Chester disease : vemurafenib: a case report

enthalten in: Journal of medical case reports | 2023

von Bozan, E. | Darçın, T. | Yaman, S. | +4

5

An effective treatment in Erdheim Chester disease: vemurafenib: a case report

enthalten in: Journal of medical case reports | 2023

von Bozan, E. | Darçın, T. | Yaman, S. | +4

6

International Forum : The Turkish perspective on apheresis activity: The Turkish apheresis registry report

enthalten in: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2023

von Ozatli, D. | Giden, A. | Erkurt, M. | +44

7

The effect of pre-conditioning immunoglobulin and absolute lymphocyte count on the outcomes of allogeneic hematopoietic cell transplantation

enthalten in: Transplant immunology | 2023

von Kaçmaz, M. | Başci, S. | Ilhan, G. | +4

8

Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma : a real-world data from Turkey

enthalten in: Annals of hematology | 2023

von Dal, M. | Ulu, B. | Uzay, A. | +17

9

Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey

enthalten in: Annals of hematology | 2022

von Dal, M. | Ulu, B. | Uzay, A. | +17

10

Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey

enthalten in: Annals of hematology | 2022

von Dal, M. | Ulu, B. | Uzay, A. | +17

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]